HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Interaction of MIF Family Proteins in Myocardial Ischemia/Reperfusion Damage and Their Influence on Clinical Outcome of Cardiac Surgery Patients.

AbstractAIMS:
Cardiac surgery involves myocardial ischemia/reperfusion (I/R) with potentially deleterious consequences. Macrophage migration inhibitory factor (MIF) is a stress-regulating chemokine-like cytokine that protects against I/R damage, but functional links with its homolog, d-dopachrome tautomerase (MIF-2), and the circulating soluble receptor CD74 (sCD74) are unknown. In this study, we investigate the role of MIF, MIF-2, sCD74, and MIF genotypes in patients scheduled for elective single or complex surgical procedures such as coronary artery bypass grafting or valve replacement.
RESULTS:
MIF and MIF-2 levels significantly increased intraoperatively, whereas measured sCD74 decreased correspondingly. Circulating sCD74/MIF complexes were detectable in 50% of patients and enhanced MIF antioxidant activity. Intraoperative MIF levels were independently associated with a reduced risk for the development of atrial fibrillation (AF) (odds ratio 0.99 [0.98-1.00]; p=0.007). Circulating levels of MIF-2, but not MIF, were associated with an increased frequency of organ dysfunction and predicted the occurrence of AF (area under the curve [AUC]=0.663; p=0.041) and pneumonia (AUC=0.708; p=0.040). Patients with a high-expression MIF genotype exhibited a reduced incidence of organ dysfunction compared with patients with low-expression MIF genotypes (3 vs. 25; p=0.042).
INNOVATION:
The current study comprehensively highlights the kinetics and clinical relevance of MIF family proteins and the MIF genotype in cardiac surgery patients.
CONCLUSION:
Our findings suggest that increased MIF levels during cardiac surgery feature organ-protective properties during myocardial I/R, while the soluble MIF receptor, sCD74, may enhance MIF antioxidant activity. In contrast, high MIF-2 levels are predictive of the development of organ dysfunction. Importantly, we provide first evidence for a gene-phenotype relationship between variant MIF alleles and clinical outcome in cardiac surgery patients.
AuthorsChristian Stoppe, Steffen Rex, Andreas Goetzenich, Sandra Kraemer, Christoph Emontzpohl, Josefin Soppert, Luisa Averdunk, Yu Sun, Rolf Rossaint, Hongqi Lue, Caleb Huang, Yan Song, Georgios Pantouris, Elias Lolis, Lin Leng, Wibke Schulte, Richard Bucala, Christian Weber, Jürgen Bernhagen
JournalAntioxidants & redox signaling (Antioxid Redox Signal) Vol. 23 Issue 11 Pg. 865-79 (Oct 10 2015) ISSN: 1557-7716 [Electronic] United States
PMID26234719 (Publication Type: Journal Article, Research Support, N.I.H., Extramural, Research Support, Non-U.S. Gov't)
Chemical References
  • Antigens, Differentiation, B-Lymphocyte
  • Biomarkers
  • Histocompatibility Antigens Class II
  • Macrophage Migration-Inhibitory Factors
  • invariant chain
  • Intramolecular Oxidoreductases
  • MIF protein, human
  • dopachrome isomerase
Topics
  • Aged
  • Animals
  • Antigens, Differentiation, B-Lymphocyte (blood)
  • Biomarkers (blood)
  • Cell Movement
  • Cells, Cultured
  • Coronary Artery Bypass
  • Female
  • Histocompatibility Antigens Class II (blood)
  • Humans
  • Intramolecular Oxidoreductases (blood, genetics)
  • Macrophage Migration-Inhibitory Factors (blood, genetics)
  • Male
  • Middle Aged
  • Myocardial Reperfusion Injury (blood)
  • Neutrophils (physiology)
  • Oxidation-Reduction
  • Polymorphism, Single Nucleotide
  • Postoperative Period
  • Protective Factors
  • Rats
  • Treatment Outcome

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: